Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Nov 5, 2026.

Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis

Bryan A. Johnson, Yiyang Zhou, Kumari G. Lokugamage and 16 more

PLOS Pathogens · 2022 · CC BY

doi:10.1101/2021.10.14.464390

Abstract

While SARS-CoV-2 continues to adapt for human infection and transmission, genetic variation outside of the spike gene remains largely unexplored. This study investigates a highly variable region at residues 203–205 in the SARS-CoV-2 nucleocapsid protein. Recreating a mutation found in the alpha and omicron variants in an early pandemic (WA-1) background, we find that the R203K+G204R mutation is sufficient to enhance replication, fitness, and pathogenesis of SARS-CoV-2. The R203K+G204R mutant corresponds with increased viral RNA and protein both in vitro and in vivo . Importantly, the R203K+G204R mutation increases nucleocapsid phosphorylation and confers resistance to inhibition of the GSK-3 kinase, providing a molecular basis for increased virus replication. Notably, analogous alanine substitutions at positions 203+204 also increase SARS-CoV-2 replication and augment phosphorylation, suggesting that infection is enhanced through ablation of the ancestral ‘RG’ motif. Overall, these results demonstrate that variant mutations outside spike are key components in SARS-CoV-2’s continued adaptation to human infection.

References 47

  1. 1.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  2. 2.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  3. 3.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  4. 4.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.chom.2021.02.020

  5. 5.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1002/pro.3909

  6. 6.
    Data, disease and diplomacy: GISAID's innovative contribution to global health · 2017
    No notice
  7. 7.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  8. 8.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1038/s41596-021-00491-8

  9. 9.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.chom.2020.04.004

  10. 10.
    Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States · 2020
    No notice
  11. 11.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1128/mbio.01174-14

  12. 12.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.celrep.2022.110829

  13. 13.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1038/s41586-020-2895-3

  14. 14.
    Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants · 2021
    Not checked
  15. 15.
    Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development · 2020
    No notice
  16. 16.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1128/jvi.62.11.4280-4287.1988

  17. 17.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1128/jvi.62.11.4288-4295.1988

  18. 18.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1128/jvi.00569-10

  19. 19.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1128/jvi.02011-09

  20. 20.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1128/jvi.01275-13

  21. 21.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1128/jvi.01287-10

  22. 22.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.virol.2021.12.004

  23. 23.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.cell.2020.06.034

  24. 24.
    Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein · 2020
    No notice
  25. 25.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.molcel.2020.08.006

  26. 26.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library

  27. 27.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.molcel.2020.11.025

  28. 28.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1073/pnas.2113401118

  29. 29.
    The Cutting Edge of Affinity Electrophoresis Technology · 2015
    Not checked
  30. 30.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.chom.2014.09.009

  31. 31.
    Glycogen Synthase Kinase-3 Regulates the Phosphorylation of Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein and Viral Replication · 2009
    No notice
  32. 32.
    The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein · 2021
    No notice
  33. 33.
    The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA · 2021
    No notice
  34. 34.
    The Coronavirus Nucleocapsid Is a Multifunctional Protein · 2014
    No notice
  35. 35.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.virusres.2004.05.002

  36. 36.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1128/jvi.79.21.13285-13297.2005

  37. 37.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1038/s41586-020-2286-9

  38. 38.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.medj.2020.07.002

  39. 39.
    SARS-CoV-2 nucleocapsid protein impairs stress granule formation to promote viral replication · 2021
    No notice
  40. 40.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1128/jvi.01925-19

  41. 41.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1016/j.jmb.2021.166875

  42. 42.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1128/jvi.79.17.11476-11486.2005

  43. 43.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1038/s41586-021-04245-0

  44. 44.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1128/mbio.00165-13

  45. 45.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1002/cpim.116

  46. 46.

    This reference’s wording can’t be shown under the paper’s licence.

    Not in our library10.1038/nmeth.1923

  47. 47.
    UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy · 2017
    No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.